Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
MedTech
Gilead inks $35M collab with AI drug discovery outfit Genesis
The deal covers three targets, with an option for more down the line.
Zoey Becker
Sep 10, 2024 11:40am
Gilead pays J&J $320M to exit licensing deal for seladelpar
Aug 9, 2024 10:30am
Chutes & Ladders—Gilead's Merdad Parsey goes, Cassava loses CEO
Jul 19, 2024 8:00am
New EHA data show how Gilead's $4.9B bet on CD47 imploded
Jun 14, 2024 2:03pm
ASCO: It's back to the basics for cancer drug developers
Jun 5, 2024 10:55am
Vir keeps pressure on Gilead with midphase hepatitis D data
Jun 5, 2024 8:52am
